Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / Ordinary Shares, nominal value EUR0.04 per share
-
Shares outstanding
-
106,324,269
-
Total 13F shares
-
19,515,607
-
Share change
-
+8,445,821
-
Total reported value
-
$375,509,129
-
Price per share
-
$19.35
-
Number of holders
-
35
-
Value change
-
+$166,447,646
-
Number of buys
-
22
-
Number of sells
-
14
Institutional Holders of ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) as of Q3 2018
As of 30 Sep 2018,
ProQR Therapeutics N.V. - Ordinary Shares, nominal value EUR0.04 per share (PRQR) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,515,607 shares.
The largest 10 holders included
RTW INVESTMENTS, LP, ADAGE CAPITAL PARTNERS GP, L.L.C., JENNISON ASSOCIATES LLC, ORBIMED ADVISORS LLC, Redmile Group, LLC, Artal Group S.A., FMR LLC, PERCEPTIVE ADVISORS LLC, Clearbridge Investments, LLC, and MORGAN STANLEY.
This page lists
35
institutional shareholders reporting positions in this security
for the Q3 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.